DUN LAOGHAIRE, Ireland (AP) _ Prothena Corp. (PRTA) on Tuesday reported a loss of $24.6 million in its third quarter.
The Dun Laoghaire, Ireland-based company said it had a loss of 62 cents per share. Losses, adjusted for restructuring gains, came to 70 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.05 per share.
The drug developer posted revenue of $255,000 in the period.
Prothena shares have decreased 66 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $12.81, a fall of 79 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTA at https://www.zacks.com/ap/PRTA